Cell name:
NCI-H69
Other names for the model:
NCI-H69、NCI-H-69、NCI H69、H69、H-69、NCIH69、NCI-HUT-69、H69/P、NCI-H69C、H69C、H69c
Cell information:
NCI-H69 cells are derived from human small cell lung cancer (SCLC), express insulin-like growth factor II, and are positive for multiple oncogenes (myc +; myb +; fes +; fms +; raf +; ras + ). Click to viewMore information.
Model information:
Subcutaneous inoculation, the mouse strain is BALB/c Nude, and matrix needs to be added during inoculation. Approximately 20 days after vaccination, the group can be divided into groups, and the administration time after grouping is approximately 42 days.Email: BD@truwaybio.com
Business: +86 185-0139-0702
Technology: +86 137-7300-5709
Website Usage Help: +86 188-6238-7270
Landline: +86 0512-80601059
Email: BD@truwaybio.com
Business: +86 185-0139-0702
Technology: +86 137-7300-5709
Website Usage Help: +86 188-6238-7270
Landline: +86 0512-80601059